MarketVector licenses MVIS Global Bionic Healthcare ESG Index

By Mary-Katherine Stinson

Lexington, Ky., Dec. 7 – MarketVector Indexes announced it has licensed the MVIS Global Bionic Healthcare ESG Index, under the ticker “Mvbion,” to underlie the VanEck Bionic Engineering UCITS ETF, according to a press release Wednesday.

The index will have a base date of Dec. 31, 2020 and a base value of 1,000.

It is weighted by free float market capitalization and reviewed on a quarterly basis. The index is calculated in dollars as a price index and a total return net index.

Capping factors are applied to avoid overweighting.

The index, which has 25 components, includes companies that generate at least 50% of their revenue from medical, dental, or vision-related implants, bioprinting, prosthesis, or preservation of organs and tissue.

MarketVector Indexes is a regulated benchmark administrator in Europe, incorporated in Germany and registered with the Federal Financial Supervisory Authority (BaFin).

© 2015 Prospect News.
All content on this website is protected by copyright law in the U.S. and elsewhere. For the use of the person downloading only.
Redistribution and copying are prohibited by law without written permission in advance from Prospect News.
Redistribution or copying includes e-mailing, printing multiple copies or any other form of reproduction.